BioCardia (BCDA) stock: insider trades, news & valuation
Health Care · Net buyingShare price and insider trades
BioCardia insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $104K and 0 sold $0 of BCDA stock on the open market.
Get emailed when insiders cluster-buy stocks like BCDA
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
BCDA insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $31K | 13 | — | 0 |
| Q2 2026 | $129K | 12 | — | 0 |
| Q1 2026 | $8K | 5 | — | 0 |
| Q4 2025 | $1K | 2 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 BioCardia, Inc. insider reported open-market purchases totaling $104K, while 0 insiders reported sales totaling $0.
BCDA stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
- 8-K Other material event
- 8-K Other material event
- 8-K Other material event
- 8-K Other material event
- 8-K Other material event
- 8-K Investor disclosure
- 8-K Listing notice
- 8-K Earnings release
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 30SEC | Peter AltmanCEO, President | Buy | 1,000384,885 held (+0%) | $1.03 | $1K | +1.0% | — |
| Sep 23SEC | Peter AltmanCEO, President | Buy | 1,900383,885 held (+0%) | $1.05 | $2K | -1.0% | — |
| Sep 4SEC | Peter AltmanCEO, President | Buy | 800381,985 held (+0%) | $1.09 | $872 | -4.6% | — |
| Aug 18SEC | Peter AltmanCEO, President | Buy | 5,400381,115 held (+1%) | $0.93 | $5K | +11.8% | — |
| Aug 13SEC | Peter AltmanCEO, President | Buy | 1,900375,785 held (+1%) | $0.92 | $2K | +13.0% | — |
| Jul 29SEC | Peter AltmanCEO, President | Buy | 5,000373,885 held (+1%) | $0.78 | $4K | +33.3% | — |
| Jul 20SEC | Peter AltmanCEO, President | Buy | 500368,885 held (+0%) | $0.83 | $415 | +25.3% | — |
| Jul 15SEC | Peter AltmanCEO, President | Buy | 2,800366,885 held (+1%) | $0.88 | $2K | +18.2% | — |
| Jul 15SEC | Peter AltmanCEO, President | Buy | 1,500368,385 held (+0%) | $0.86 | $1K | +20.9% | — |
| Jul 10SEC | Peter AltmanCEO, President | Buy | 5,500367,485 held (+2%) | $0.97 | $5K | +7.2% | — |
| Jul 10SEC | Peter AltmanCEO, President | Buy | 1,000369,485 held (+0%) | $0.94 | $940 | +10.6% | — |
| Jul 10SEC | Peter AltmanCEO, President | Buy | 1,000368,485 held (+0%) | $0.90 | $900 | +15.6% | — |
| Jul 8SEC | Peter AltmanCEO, President | Buy | 5,400361,985 held (+2%) | $0.96 | $5K | +8.3% | — |
| Jun 24SEC | Simon H StertzerDirector | Buy | 70,200127,338 held (+123%) | $0.92 | $65K | +13.0% | — |
| Jun 24SEC | Simon H StertzerDirector | Buy | 39,000166,338 held (+31%) | $1.00 | $39K | +4.0% | — |
| Jun 22SEC | Peter AltmanCEO, President | Buy | 1,500299,766 held (+1%) | $0.85 | $1K | +22.4% | — |
| Jun 22SEC | Peter AltmanCEO, President | Buy | 800300,566 held (+0%) | $0.96 | $768 | +8.3% | — |
| Jun 9SEC | Peter AltmanCEO, President | Buy | 5,000298,266 held (+2%) | $0.85 | $4K | +22.4% | — |
| May 21SEC | Peter AltmanCEO, President | Buy | 1,500293,266 held (+1%) | $0.92 | $1K | +13.0% | — |
| May 21SEC | Peter AltmanCEO, President | Buy | 200291,766 held (+0%) | $0.95 | $190 | +9.5% | — |
| May 18SEC | Peter AltmanCEO, President | Buy | 5,700291,566 held (+2%) | $0.92 | $5K | +13.0% | — |
| May 15SEC | Peter AltmanCEO, President | Buy | 5,100285,866 held (+2%) | $1.02 | $5K | +2.0% | — |
| Apr 29SEC | Peter AltmanCEO, President | Buy | 5,000280,766 held (+2%) | $1.11 | $6K | -6.3% | — |
| Apr 22SEC | Peter AltmanCEO, President | Buy | 600275,366 held (+0%) | $1.23 | $738 | -15.4% | — |
| Apr 22SEC | Peter AltmanCEO, President | Buy | 400275,766 held (+0%) | $1.23 | $492 | -15.4% | — |
| Mar 26SEC | Peter AltmanCEO, President | Buy | 600274,466 held (+0%) | $1.24 | $744 | -16.1% | — |
| Mar 26SEC | Peter AltmanCEO, President | Buy | 300274,766 held (+0%) | $1.22 | $366 | -14.8% | — |
| Feb 4SEC | Peter AltmanCEO, President | Buy | 5,000273,866 held (+2%) | $1.13 | $6K | -8.0% | — |
| Jan 21SEC | Peter AltmanCEO, President | Buy | 600268,566 held (+0%) | $1.32 | $792 | -21.2% | — |
| Jan 21SEC | Peter AltmanCEO, President | Buy | 300268,866 held (+0%) | $1.34 | $402 | -22.4% | — |
| Dec 17SEC | Peter AltmanCEO, President | Buy | 900267,966 held (+0%) | $1.30 | $1K | -20.0% | — |
| Dec 17SEC | Peter AltmanCEO, President | Buy | 200267,066 held (+0%) | $1.37 | $274 | -24.1% | — |
Insiders at BioCardia, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Simon H StertzerDirector | $104K | — | Jun 24, 2026 | — |
| Peter AltmanCEO, President | $66K | — | Sep 30, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
BCDA stock: common questions
Are BioCardia, Inc. insiders buying BCDA stock?
In the past 12 months, 1 insiders reported open-market purchases of BCDA worth $104K. The latest was CEO, President Peter Altman bought $1K of BCDA at $1.03.
Are BioCardia, Inc. insiders selling BCDA stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is BCDA's 52-week range?
Over the past year BCDA has traded between $0.77 and $1.56. It last closed at $1.04 on Oct 9, 2026.